American Journal of Cardiology
Volume 101, Issue 12 , Pages 1683-1688, 15 June 2008

Cholesterol Ester Transfer Protein, Interleukin-8, Peroxisome Proliferator Activator Receptor Alpha, and Toll-Like Receptor 4 Genetic Variations and Risk of Incident Nonfatal Myocardial Infarction and Ischemic Stroke

  • Daniel A. Enquobahrie, MD, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Corresponding Author InformationCorresponding author: Tel: 617-432-7153; fax: 617-432-2435.
  • ,
  • Nicholas L. Smith, MPH, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Seattle Epidemiologic Research and Information Center for the Department of Veterans Affairs Office of Research and Development, Seattle, Washington
  • ,
  • Joshua C. Bis, MS, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
  • ,
  • Cara L. Carty, MS

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
  • ,
  • Kenneth M. Rice, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Biostatistics, University of Washington, Seattle, Washington
  • ,
  • Thomas Lumley, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Biostatistics, University of Washington, Seattle, Washington
  • ,
  • Lucia A. Hindorff, MPH, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
  • ,
  • Rozenn N. Lemaitre, MPH, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
  • ,
  • Michelle A. Williams, DSc

      Affiliations

    • Department of Epidemiology, University of Washington, Seattle, Washington
  • ,
  • David S. Siscovick, MD, MPH

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
  • ,
  • Susan R. Heckbert, MD, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Center for Health Studies, Group Health, Seattle, Washington.
  • ,
  • Bruce M. Psaty, MD, PhD

      Affiliations

    • Cardiovascular Health Research Unit, University of Washington, Seattle, Washington
    • Department of Epidemiology, University of Washington, Seattle, Washington
    • Department of Medicine, University of Washington, Seattle, Washington
    • Department of Health Services, University of Washington, Seattle, Washington
    • Center for Health Studies, Group Health, Seattle, Washington.

Received 6 November 2007; received in revised form 6 February 2008; accepted 6 February 2008. published online 10 April 2008.

Variations in candidate genes participating in oxidative stress, inflammation, and their interactions are potentially associated with diseases of atherosclerotic origin. We investigated independent and joint associations of variations in cholesterol ester transfer protein (CETP), interleukin-8 (IL8), peroxisome proliferator activator receptor-α (PPARA), and Toll-like receptor 4 (TLR4) genes with incident nonfatal myocardial infarction (MI) or ischemic stroke. In a population-based case–control study, patients (848 with MI and 368 with ischemic stroke) and controls (2,682) were recruited from postmenopausal women and hypertensive men/women who were members of Group Health in western Washington State. Common tag single-nucleotide polymorphisms (SNPs; n = 34) representing gene-wide variations were selected from gene sequencing data using pairwise linkage disequilibrium. Haplotypes were inferred using a modified expectation maximization algorithm. Multivariate logistic regression evaluated individual haplotype and SNP-disease associations in log-additive models. Global haplotype tests assessed overall gene–disease associations. Logic regression was used to evaluate gene–gene interactions. False discovery rates and permutation tests were used for multiple testing adjustment in evaluating independent associations and interactions, respectively. Overall, gene-wide variations in PPARA and TLR4 genes were associated with MI. The minor allele of the PPARA SNP, rs4253623, was associated with a higher risk of MI (odds ratio 1.25, 95% confidence interval 1.08 to 1.46), whereas the minor allele of the TLR4 SNP, rs1927911, was associated with a lower risk of MI (odds ratio 0.88, 95% confidence interval 0.77 to 0.99). No within-gene or gene–gene interaction was associated with MI or ischemic stroke risk. In conclusion, potential SNP–disease associations identified in the present study are novel and need further investigation.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by Grants HL73410, HL60739, HL68639, HL43201, HL74745, HL68986, and 1-T32-HL07902 from the National Health Lung and Blood Institute, Bethesda, Maryland.

PII: S0002-9149(08)00349-4

doi:10.1016/j.amjcard.2008.02.052

American Journal of Cardiology
Volume 101, Issue 12 , Pages 1683-1688, 15 June 2008